tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RPTX Stock Latest News

Repare Therapeutics announces CRADA to advance camonsertib development
The FlyRepare Therapeutics announces CRADA to advance camonsertib development
10d ago
RPTX
Repare Therapeutics Reports Q3 2024 Progress and Outlook
PremiumCompany Announcements
Repare Therapeutics Reports Q3 2024 Progress and Outlook
14d ago
RPTX
Repare Therapeutics reports Q3 EPS (81c), consensus (83c)
PremiumThe Fly
Repare Therapeutics reports Q3 EPS (81c), consensus (83c)
15d ago
RPTX
Repare Therapeutics presents data from Phase 1 MYTHIC clinical trial
PremiumThe Fly
Repare Therapeutics presents data from Phase 1 MYTHIC clinical trial
30d ago
RPTX
Repare Therapeutics doses first patient in POLAR trial
PremiumThe Fly
Repare Therapeutics doses first patient in POLAR trial
1M ago
RPTX
Repare Therapeutics reports ‘encouraging’ Phase 1 camonsertib combo data
PremiumThe FlyRepare Therapeutics reports ‘encouraging’ Phase 1 camonsertib combo data
2M ago
RPTX
Repare: Endometrial cancers with CCNE1 amplifications carry poor prognosis
Premium
The Fly
Repare: Endometrial cancers with CCNE1 amplifications carry poor prognosis
2M ago
RPTX
Repare Therapeutics Announces Strategic R&D Focus and Workforce Reduction
Premium
Company Announcements
Repare Therapeutics Announces Strategic R&D Focus and Workforce Reduction
3M ago
8K
RPTX
Repare announces strategic reprioritization, to lay off 25% of workforce
PremiumThe Fly
Repare announces strategic reprioritization, to lay off 25% of workforce
3M ago
RPTX
Repare to provide updated camonsertib data in Q4, says LifeSci Capital
PremiumThe Fly
Repare to provide updated camonsertib data in Q4, says LifeSci Capital
3M ago
RPTX
Repare Therapeutics Advances Oncology Trials and Preps for 2025
PremiumCompany Announcements
Repare Therapeutics Advances Oncology Trials and Preps for 2025
4M ago
RPTX
Repare Therapeutics files $350M mixed securities shelf
PremiumThe Fly
Repare Therapeutics files $350M mixed securities shelf
4M ago
RPTX
Repare Therapeutics expects cash to fund operations into mid-2026
PremiumThe FlyRepare Therapeutics expects cash to fund operations into mid-2026
4M ago
RPTX
Repare Therapeutics reports Q2 EPS (82c), consensus (87c)
Premium
The Fly
Repare Therapeutics reports Q2 EPS (82c), consensus (87c)
4M ago
RPTX
Repare Therapeutics management to meet virtually with Piper Sandler
Premium
The Fly
Repare Therapeutics management to meet virtually with Piper Sandler
4M ago
RPTX
Repare Therapeutics announces intial data from Phase 1 MINOTAUR trial
PremiumThe Fly
Repare Therapeutics announces intial data from Phase 1 MINOTAUR trial
5M ago
RPTX
Repare Therapeutics doses first patient in camonsertib trial
PremiumThe Fly
Repare Therapeutics doses first patient in camonsertib trial
5M ago
RPTX
Repare announces FDA fast track designation for Lunresertib-Camonsertib combo
PremiumThe Fly
Repare announces FDA fast track designation for Lunresertib-Camonsertib combo
6M ago
RPTX
Repare Therapeutics Advances Oncology Trials
PremiumCompany Announcements
Repare Therapeutics Advances Oncology Trials
7M ago
RPTX
Repare Therapeutics reports Q1 EPS 30c, consensus 2c
PremiumThe FlyRepare Therapeutics reports Q1 EPS 30c, consensus 2c
7M ago
RPTX
Repare Therapeutics, Debiopharm dose first patient in Module 4 of MYTHIC trial
Premium
The Fly
Repare Therapeutics, Debiopharm dose first patient in Module 4 of MYTHIC trial
7M ago
RPTX
Repare Therapeutics Announces Board Changes and FD Disclosure
Premium
Company Announcements
Repare Therapeutics Announces Board Changes and FD Disclosure
7M ago
8K
RPTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >